Category: San Jose BioCenter
Application Deadline August 6, 2010
The National Cancer Institute (NCI) recently introduced the Small Business Innovation Research (SBIR) Phase II Bridge Award mechanism, designed to incentivize their phase II awardees to obtain 3rd party financing in order commercialize technologies developed with SBIR funds.
In this session, Directors from the NCI SBIR Development Center will talk to current and potential grantees about the Bridge Award and other opportunities such as their contract topics.
After the presentation, each attendee will have a private meeting with Mr. Michael Weingarten – the Director of the NCI SBIR Development Center – and/or Dr. Ali Andalibi – the Program Director of the NCI SBIR Development Center.
To apply for one-on-one meetings, please send your Executive Summary by August 6, 2010 toevents@sjbiocenter.com. The Review Board, composed of the BioCenter management team, sponsors, partners and mentors, will then meet to consider your application.
Date: July 22, 2010
Time: 5:00PM
Venue: San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Cost: Application free | Registration from $150 to $175
Emerging companies find it increasingly difficult to reach the right person when seeking funding. It is equally difficult for companies with funds to allocate to wade through countless proposals in search of the right opportunity that aligns with their investment strategy and in some cases their mission. Through the “Meet with…” Series, we provide emerging life science companies with greater access to partnering and/or financing opportunities. On August 17, Martin Eglitis, Ph.D. Senior Partnering Director at Teva Innovative Ventures will explain what they are looking for in a company. After the presentation, attendees will have lunch with Dr Eglitis. Finally, each pre-approved attendee*
*Registrations to one-on-one meetings are subject to approval of application.
Attendees must apply and be approved to attend. To apply, please send your Executive Summary by July 22, 2010 to events@sjbiocenter.com. The Review Board, composed of the BioCenter management team, sponsors, partners and mentors, will then meet to consider your application. | Application fee: free | Registration fee: from $150 to $175 | 9:00-5:00 | @ the San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Date: August 17, 2010
Time: 9:00AM-5:00PM
Venue: San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Cost: Application free | Registration from $150 to $175
Emerging companies find it increasingly difficult to reach the right person when seeking funding. It is equally difficult for companies with funds to allocate to wade through countless proposals in search of the right opportunity that aligns with their investment strategy and in some cases their mission. Through the “Meet with…” Series, we provide emerging life science companies with greater access to partnering and/or financing opportunities. On August 17, Martin Eglitis, Ph.D. Senior Partnering Director at Teva Innovative Ventures will explain what they are looking for in a company. After the presentation, attendees will have lunch with Dr Eglitis. Finally, each pre-approved attendee* will be granted a private meeting with Dr Eglitis.
*Registrations to one-on-one meetings are subject to approval of application.
Attendees must apply and be approved to attend. To apply, please send your Executive Summary by July 22, 2010 to events@sjbiocenter.com. The Review Board, composed of the BioCenter management team, sponsors, partners and mentors, will then meet to consider your application. | Application fee: free | Registration fee: from $150 to $175 | 9:00-5:00 | @ the San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Date: May 30, 2010
Time: 5:00PM
Venue: San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Cost: Application free | Registration from $150 to $175
Emerging companies find it increasingly difficult to reach the right person when seeking funding. It is equally difficult for companies with funds to allocate to wade through countless proposals in search of the right opportunity that aligns with their investment strategy and in some cases their mission. Through the “Meet with…” Series, we provide emerging life science companies with greater access to partnering and/or financing opportunities. On June 23, members of Gilead will talk to potential licensees to first explain what they are looking for in a company. After the presentation, attendees will have lunch with the Gilead team. Finally, each pre-approved attendee* will be granted a private meeting with a member of the Gilead team.
*Registrations to one-on-one meetings are subject to approval of application.
Attendees must apply and be approved to attend. To apply, please send your Executive Summary by May 30, 2010 to events@sjbiocenter.com. The Review Board, composed of the BioCenter management team, sponsors, partners and mentors, will then meet to consider your application. | Application fee: free | Registration fee: from $150 to $175 | 9:00-5:00 | @ the San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
More info: http://www.sjbiocenter.com/event/ev_2010Q2-MeetWithGilead.html
Date: September 28, 2010
Time: 9:00AM-5:00PM
Venue: San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Cost: Application free | Registration from $150 to $175
Emerging companies find it increasingly difficult to reach the right person when seeking funding. It is equally difficult for companies with funds to allocate to wade through countless proposals in search of the right opportunity that aligns with their investment strategy and in some cases their mission. Through the “Meet with…” Series, we provide emerging life science companies with greater access to partnering and/or financing opportunities. On September 28, Licensing Directors from Merck & Co., Inc. will talk to potential licensees to first explain what they are looking for in a company. After the presentation, attendees will have lunch with the Merck team. Finally, each pre-approved attendee* will be granted a private meeting with Dr. James M. Schaeffer - the Executive Director of Licensing & External Research for Merck Research Laboratories at Merck & Co., Inc. - or Dr. Yael Weiss - the Director of Licensing & External Research for Merck Research Laboratories at Merck & Co., Inc. They are interested in meeting with companies from all therapeutic areas at all stages of development including enabling technologies.
*Registrations to one-on-one meetings are subject to approval of application.
Attendees must apply and be approved to attend. To apply, please send your Executive Summary by September 3, 2010 to events@sjbiocenter.com. The Review Board, composed of the BioCenter management team, sponsors, partners and mentors, will then meet to consider your application. | Application fee: free | Registration fee: from $150 to $175 | 9:00-5:00 | @ the San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
More info: http://www.sjbiocenter.com/event/ev_2010Q3-MeetWithMerck.html
Date: September 23, 2010
Time: 3:00PM-6:30PM
Venue: Orrick, Herrington & Sutcliffe LLP, 1000 Marsh Road, Menlo Park CA 94025-1015
Registration Cost: from $0 to $60
From alliance to funding, Big Pharma and established biotech companies are increasingly investing in emerging companies. This Panel brings together executives from these larger companies to identify the type of deals now available to smaller companies, how to secure them, and how to manage them. Questions that will be raised include: What are the best approaches for identifying a good partner? What type of partnerships are commonly used? And is your company a best candidate for a license, or a joint venture, or a M&A? What about Big Pharma VC Funds? What are the strategies for attracting, securing and structuring strategic investments? How the Larger Bio-Companies’ needs differ from VCs’ needs? What are the key contract terms to be negotiated? What are the strategic reasoning behind different kinds partnerships? Effects on existing and potential future collaboration partners and other strategic decisions. Pros and cons of a small company partnering with a larger company. “Dos” and “don’ts” of managing these important relationships. Etc. Our Panel discussions are candid, interactive and informal. We want you to walk away with the real story behind how things work so you can make it happen yourself. This Panel will be followed by a Networking Reception. | Registration fee: from $0 to $60 | 3:00-6:30 | @ Orrick, Herrington & Sutcliffe LLP, 1000 Marsh Road, Building 1100, Menlo Park CA 94025-1015
More info and registration: http://www.sjbiocenter.com/event/ev_2010Q3-DoingDealsWithBigPharma.html
Date: September 3, 2010
Time: 5:00PM
Venue: San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Cost: Application free | Registration from $150 to $175
Emerging companies find it increasingly difficult to reach the right person when seeking funding. It is equally difficult for companies with funds to allocate to wade through countless proposals in search of the right opportunity that aligns with their investment strategy and in some cases their mission. Through the “Meet with…” Series, we provide emerging life science companies with greater access to partnering and/or financing opportunities. On September 28, Licensing Directors from Merck & Co., Inc. will talk to potential licensees to first explain what they are looking for in a company. After the presentation, attendees will have lunch with the Merck team. Finally, each pre-approved attendee* will be granted a private meeting with Dr. James M. Schaeffer - the Executive Director of Licensing & External Research for Merck Research Laboratories at Merck & Co., Inc. - or Dr. Yael Weiss - the Director of Licensing & External Research for Merck Research Laboratories at Merck & Co., Inc. They are interested in meeting with companies from all therapeutic areas at all stages of development including enabling technologies.
*Registrations to one-on-one meetings are subject to approval of application.
Attendees must apply and be approved to attend. To apply, please send your Executive Summary by September 3, 2010 to events@sjbiocenter.com. The Review Board, composed of the BioCenter management team, sponsors, partners and mentors, will then meet to consider your application. | Application fee: free | Registration fee: from $150 to $175 | 9:00-5:00 | @ the San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Date: April 27, 2010
Time: 8:30AM-11:15AM
Venue: Townsend and Townsend and Crew LLP, 379 Lytton Ave., Palo Alto, CA 94301
Registration Cost: from $0 to $30
Maximizing the value of your BioPharma IP begins with being strategic about your end-game. You want to pay less and achieve more from your innovations and investments, and to minimize the risk of losing ownership or control over what’s rightfully yours. The smart approach? Develop an IP strategy that considers your full potential for licensing, investment, merger and acquisition while delivering full protection for your patentable assets. Join startup strategists from Townsend & Townsend, Aquilo Partners and SageSpring Partners to learn how companies today are managing to get more bang for their buck by developing integrated IP strategies that minimize their risks and maximize their investment value.
Speakers include: William Kezer, Partner, Townsend and Townsend and Crew LLP - Marc Schneidman, Managing Director, Acquilo Partners - Leslie Lippard, Partner, Sage Spring Partners - Moderator: Richard Hsu, Partner, Townsend and Townsend and Crew LLP | Registration fee: from $0 to $30 | 8:30-11:15 | @ Townsend and Townsend and Crew LLP, 379 Lytton Ave., Palo Alto, CA 94301
More info and registration: http://www.sjbiocenter.com/event/ev_2010Q2-MaximizeIPvalue.html
Date: June 23, 2010
Time: 9:00AM-4:00PM
Venue: San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Application Cost: free
Registration Cost: from $150 to $175
Through the “Meet with…” Series, we provide you with greater access to partnering and financing opportunities. In this session, members of Gilead will talk to potential licensees to first explain what they are looking for in a company. After the presentation, attendees will have lunch with the Gilead team. Finally, each pre-approved attendee* will be granted a private meeting with a member of the Gilead team.
*Attendees must apply and be approved to attend the one-on-one meetings. To apply, please send your Executive Summary to aurelie@sjbiocenter.com. The Review Board, composed of the BioCenter management team, sponsors, partners and mentors, will then meet to consider your application. | Application fee: free | Registration fee: from $150 to $175 | 9:00-4:00 | @ the San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Date: April 22, 2010
Time: 9:00AM-4:00PM
Venue: San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Application Cost: free
Registration Cost: from $150 to $175
Emerging companies find it increasingly difficult to reach the right person when seeking funding. It is equally difficult for companies with funds to allocate to wade through countless proposals in search of the right opportunity that aligns with their investment strategy and in some cases their mission. Through the “Meet with…” Series, we provide emerging life science companies with greater access to partnering and/or financing opportunities. Attendees must apply and be approved to attend. To apply, please send your Executive Summary to Aurélie at aurelie@sjbiocenter.com. The Review Board, composed of the BioCenter management team, sponsors, partners and mentors, will then meet to consider your application. | Application fee: free | Registration fee: from $150 to $175 | 9:00-4:00 | @ the San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
